All data are based on the daily closing price as of February 27, 2026
a
Alfresa Holdings
2784.TSE
17.15 USD
0.40
+2.39%
Overview
Last close
17.15 usd
Market cap
3.12B usd
52 week high
17.15 usd
52 week low
13.07 usd
Target price
14.74 usd
Valuation
P/E
17.0377
Forward P/E
N/A
Price/Sales
0.159
Price/Book Value
0.9805
Enterprise Value
1.88B usd
EV/Revenue
0.0969
EV/EBITDA
5.6983
Key financials
Revenue TTM
19.45B usd
Gross Profit TTM
1.39B usd
EBITDA TTM
346.32M usd
Earnings per Share
0.87 usd
Dividend
0.42 usd
Total assets
10.39B usd
Net debt
-1.14B usd
About
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is also involved in the operation of dispensing pharmacies and conducting related businesses; ethical pharmaceuticals wholesaling business; self-medication products wholesaling business; and other medical-related businesses. In addition, the company manufactures and markets active pharmaceutical ingredients; contract distribution services in hospitals; operation, maintenance, and development of information system; supply of cell raw materials; manufacturing of specific processed cells and regenerative medicine products. The company was incorporated in 2003 and is based in Tokyo, Japan.